Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-32,425
Closed -$486K 611
2019
Q2
$486K Hold
32,425
0.03% 486
2019
Q1
$466K Hold
32,425
0.02% 482
2018
Q4
$464K Sell
32,425
-5,705
-15% -$89.4K 0.03% 470
2018
Q3
$618K Buy
38,130
+2,420
+7% +$39K 0.03% 454
2018
Q2
$564K Buy
35,710
+510
+1% +$8.81K 0.01% 468
2018
Q1
$633K Buy
35,200
+5,175
+17% +$93.6K 0.02% 452
2017
Q4
$509K Buy
30,025
+825
+3% +$14K 0.01% 490
2017
Q3
$473K Hold
29,200
0.01% 503
2017
Q2
$455K Hold
29,200
0.01% 510
2017
Q1
$434K Buy
29,200
+7,200
+33% +$112K 0.01% 497
2016
Q4
$342K Buy
+22,000
New +$338K 0.01% 544

Other funds holding IX

Boston Advisors's IX Position: Q3 2019 in Review

Boston Advisors sold out of ORIX (IX) in Q3 2019, closing a stake of 32,425 shares — an estimated $486K sold.

Boston Advisors first reported a position in IX in Q4 2016 and held it in 11 quarters. The position peaked at $633K in Q1 2018. 110 funds tracked by Wall St. Rank hold IX as of Q3 2019.

  • Boston Advisors reported no remaining ORIX position as of Q3 2019 after selling out during the quarter.
  • Boston Advisors sold 32,425 ORIX shares in Q3 2019, an estimated $486K.
  • Boston Advisors first reported a position in ORIX in Q4 2016 and held it in 11 quarters.
  • Boston Advisors's ORIX position peaked at $633K in Q1 2018.
  • 110 funds tracked by Wall St. Rank held ORIX as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.